# Caffeine Citrate Use and Electronic Activity of the Diaphragm (EDI) Changes

> **NCT05393817** · — · COMPLETED · sponsor: **Seoul St. Mary's Hospital** · enrollment: 14 (actual)

## Conditions studied

- Preterm
- Apnea of Prematurity
- Caffeine

## Interventions

- **DRUG:** caffeine citrate

## Key facts

- **NCT ID:** NCT05393817
- **Lead sponsor:** Seoul St. Mary's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-08
- **Primary completion:** 2023-10-18
- **Final completion:** 2023-10-18
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2023-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05393817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05393817, "Caffeine Citrate Use and Electronic Activity of the Diaphragm (EDI) Changes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05393817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*